These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33520746)

  • 1. Occurrence of psychotic symptoms during treatment of ADHD with methylphenidate: Clinical significance and the need for further research.
    Reiersen AM
    Scand J Child Adolesc Psychiatr Psychol; 2018; 6(1):1-3. PubMed ID: 33520746
    [No Abstract]   [Full Text] [Related]  

  • 2. Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis
    Ramstad E; Storebø OJ; Gerner T; Krogh HB; Holmskov M; Magnusson FL; Moreira-Maia CR; Skoog M; Groth C; Gillies D; Zwi M; Kirubakaran R; Gluud C; Simonsen E
    Scand J Child Adolesc Psychiatr Psychol; 2018; 6(1):52-71. PubMed ID: 33520751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ADHD during childhood and subsequent psychotic disorder: A link?].
    Gering A; Fourneret P; Poulet E; Geoffray MM; Jurek L
    Encephale; 2021 Oct; 47(5):484-490. PubMed ID: 33994156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD.
    Ghadrdan E; Mousavi M; Ghaeli P
    Iran J Psychiatry; 2018 Oct; 13(4):310-313. PubMed ID: 30627205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
    Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
    Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study.
    Hollis C; Chen Q; Chang Z; Quinn PD; Viktorin A; Lichtenstein P; D'Onofrio B; Landén M; Larsson H
    Lancet Psychiatry; 2019 Aug; 6(8):651-658. PubMed ID: 31221557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD.
    Bieś R; Fojcik J; Warchala A; Trędzbor B; Krysta K; Piekarska-Bugiel K; Krzystanek M
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylphenidate treatment for attention-deficit/hyperactivity disorder in children and adolescents with velocardiofacial syndrome: an open-label study.
    Gothelf D; Gruber R; Presburger G; Dotan I; Brand-Gothelf A; Burg M; Inbar D; Steinberg T; Frisch A; Apter A; Weizman A
    J Clin Psychiatry; 2003 Oct; 64(10):1163-9. PubMed ID: 14658963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Epstein T; Patsopoulos NA; Weiser M
    Cochrane Database Syst Rev; 2014 Sep; (9):CD005041. PubMed ID: 25230710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.
    Castells X; Cunill R; Capellà D
    Eur J Clin Pharmacol; 2013 Mar; 69(3):347-56. PubMed ID: 22983311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
    Storebø OJ; Pedersen N; Ramstad E; Kielsholm ML; Nielsen SS; Krogh HB; Moreira-Maia CR; Magnusson FL; Holmskov M; Gerner T; Skoog M; Rosendal S; Groth C; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Håkonsen SJ; Aagaard L; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012069. PubMed ID: 29744873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II).
    Asherson P; Johansson L; Holland R; Fahy T; Forester A; Howitt S; Lawrie S; Strang J; Young S; Landau S; Thomson L
    Trials; 2019 Dec; 20(1):663. PubMed ID: 31791384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Methylphenidate on Somatic Symptoms and Brain Functional Connectivity in Adolescents with Attention Deficit Hyperactivity Disorder: A Pilot Study.
    Kim SM; Min KJ; Han DH
    Clin Psychopharmacol Neurosci; 2022 May; 20(2):259-270. PubMed ID: 35466097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate.
    Edebol H; Helldin L; Norlander T
    Clin Pract Epidemiol Ment Health; 2013; 9():171-9. PubMed ID: 24265648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome.
    Basel D; Mosheva M; Maeder J; Schneider M; Shani S; Weinberger R; Eliez S; Gothelf D
    Eur Child Adolesc Psychiatry; 2022 Sep; 31(9):1367-1375. PubMed ID: 33871687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
    Boesen K; Paludan-Müller AS; Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD012857. PubMed ID: 35201607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of children and adolescents with ADHD with or without methylphenidate prescription at their first diagnostic assessment.
    De Rossi P; Pretelli I; Menghini D; D'Aiello B; Di Vara S; Vicari S
    Eur Arch Psychiatry Clin Neurosci; 2022 Dec; 272(8):1437-1442. PubMed ID: 35211779
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.